Overall paediatric consumer health in Brazil is predicted to continue to register dynamic current value growth in 2024, presenting even better results than in the previous year. Despite the decline in cases of arboviruses such as dengue over the course of 2024, the demand for paediatric dipyrone has continued to rise. Dipyrone, along with paracetamol, remains one of the safest options for easing the symptoms of dengue, as it does not increase the risk of bleeding, unlike other OTC medications, s

Paediatric consumer health is set to experience steady mid-single-digit retail current value growth in India in 2024. A significant driver of this performance is the increasing concern amongst parents about ensuring their children receive the proper nutrition. Many parents are busy, and struggle to find time to prepare balanced meals, which makes paediatric vitamins and dietary supplements a convenient and essential option for fulfilling their children’s nutritional needs.

In Singapore, aside from vitamins and dietary supplements, products specifically targeting children's health are still relatively limited. Parents are generally advised to adjust adult dosages when administering medications to children to ensure proper efficacy and safety. However, as awareness around children's health grows, there has been a shift towards more specialised offerings tailored to paediatric needs.

Paediatric consumer health recorded retail value sales growth in 2024, with mixed results for volume, depending on the product area. Paediatric cough/cold medications decreased in demand, with consumers reverting back to home remedies and/or doctor-prescribed products for more severe cases. However, areas such as digestive remedies recorded strong growth. These products benefitted from children eating out more, while levels of stress also contributed to an increase in diarrhoeal diseases. Furthe

Paediatric consumer health in Germany is recording moderate retail value growth in 2024, driven primarily by paediatric cough/cold remedies. Another product category to gain visibility is paediatric vitamins and dietary supplements due to the preventative trend among German parents. Analgesics, another important product area, sees value sales divided between acetaminophen and ibuprofen, while nappy (diaper) rash treatments also holds considerable value share, and remains resilient despite the co

The paediatric consumer health market in Indonesia is projected to grow faster than the overall market in 2024, despite a decline in the child population. This trend is driven by the increasing importance parents place on their offsprings’ wellness and wellbeing. As a result, products designed for children, whether to treat specific illnesses or maintain general health, continue to perform well.

The paediatric consumer health market in Romania is experiencing significant expansion, driven by a heightened awareness of child health and wellbeing. As parents become more informed about their children's health needs, consumer health manufacturers are increasingly looking to broaden their portfolios to include paediatric medicines and supplements. Indeed, many leading companies in Romania already offer specialised products for children. In paediatric analgesics, for example, Reckitt Benckiser

Paediatric consumer health is seeing mixed results in Cameroon in 2024, depending on the type of product. Analgesics, and cough, cold, and allergy remedies tend to be the most popular, as these products deal with common and familiar ailments in children, such as fever, cough, and catarrh. They are also. easy to administer and provide effective relief with minimal side effects. Additionally, children are more susceptible to severe and longer lasting coughs and catarrh during the dry season, foste

Despite slowing birth rates in North Macedonia, paediatric consumer health has performed reasonably well in 2024, with overall current value growth remaining strong and all categories expanding in volume terms. Sales continue to be buoyed by rising health-consciousness, which is making parents more confident about self-medicating their children. Moreover, together with advice from doctors and pharmacists, the same factor means consumers increasingly recognise that aside from being safer than giv

Paediatric consumer health is expected to register moderate value growth in 2024. Vitamins and dietary supplements continue to be the largest product areas in terms of value sales, with vitamin D being one of the bestsellers, as it is recommended by doctors, especially during the winter months when sunlight is limited. Other products gaining visibility are fish oil based gummies from Mollers. Analgesics is the second biggest product area, with value sales almost equally divided between acetamino

Paediatric consumer health reported a sharp rebound in current value sales over 2024 due to price increases. However, consumption weakened due to the shortage of several international brands imported by the Tunisian Central Pharmacy. The lower purchasing power of Tunisian parents has also hampered retail volume sales, as well as the decrease in visits to see paediatric doctors.

Rising consumer interest in child-specific consumer health products and self-medication in general is driving further growth of paediatric consumer health in Slovenia in 2024. Natural and ‘clean’ products are increasingly preferred, as parents want to limit their children's exposure to artificial and potentially harmful chemicals, therefore there is an increased interest in natural herbal/traditional remedies within various paediatric categories. Despite the challenging economic climate, Sloveni

In 2024, paediatric consumer health registered an increase in constant value growth, as inflation decreased, and the Swedish economy began to improve. The category has received an impetus from the influx of refugees from Ukraine - predominantly women and children – which has increased the child population in Sweden. Nonetheless, paediatric consumer health remains a minor part of total consumer health in Sweden as children are usually treated with general products (suitable for adults and childre

In general, paediatric consumer health recorded strong retail volume growth during the early-to-mid-review period, with the outbreak of Coronavirus (COVID-19) in 2020 providing a particular boost to demand. However, as the pandemic threat eased, the demand for paediatric consumer health stabilised, with numerous categories seeing declines in retail volume sales towards the end of the review period. Nonetheless, growing awareness of children’s health and specific needs among Turkish parents is ri

In Uzbekistan in 2024, the paediatric remedies segment is experiencing a noteworthy increase in both retail volume and value sales. This encouraging trend is largely underpinned by the nation's positive annual birth rate and the prioritisation of children's health. As paediatric medicines continue to rise in popularity, market players are increasingly eager to expand their portfolios to include paediatric products. However, this endeavour is fraught with the challenges of stringent regulations f

Sales of paediatric consumer health plummeted in 2022 as millions of Ukrainians fled the country with their children following Russia’s invasion of Ukraine. With Russia’s war continuing in 2023 and 2024 many families have remained abroad due to safety fears which has limited the category’s recovery. Furthermore, birth rates have also fallen due to the fear and uncertainty created by the war. Nevertheless, the category has seen healthy growth in current value terms in 2024 driven in part by risin

Paediatric consumer health is expected to register moderate current value growth in Pakistan in 2024. Cough and cold remedies continue to account for most value sales, though in 2024, it is expected that paediatric dietary supplements and vitamins will register the highest current value growth. Diarrhoeal remedies are also present , including oral hydration solutions, and there is an increasing range of favours in oral hydration solution to make them more palatable for children. Another importan

Paediatric consumer health in Taiwan remains underdeveloped, with measurable sales primarily in only two subcategories: paediatric vitamins and dietary supplements, and paediatric cough/cold remedies. This is largely due to parents traditionally opting to take their children to the doctor for even minor ailments, a behaviour supported by the accessibility and affordability of medical consultations under the country's effective national health insurance system.

Paediatric consumer health witnessed double-digit current value growth in 2024, driven by rising prices in Serbia. Retail volume sales are being hampered by a shrinking consumer base due to the declining birth rate, with volume sales of nappy (diaper) rash treatments declining in 2024. Rising consumer awareness is providing some support to volume growth although the lingering economic pressures is still a limitation for many parents. Consumers often look for the best prices across various pharma

The paediatric consumer health market in Switzerland is expected to remain flat in current value terms in 2024, as Swiss parents generally prefer to consult healthcare professionals before using any medical products for their children. Self-medication is typically reserved for minor ailments that are judged not to require medical advice. Few categories within paediatric consumer health are particularly popular, as many parents are sceptical about pharmacy-only products and are cautious about pot

The rising cost of living in Kenya is pushing consumers to seek more affordable options in paediatric consumer health. Parents are increasingly turning to locally produced or generic brands, such as Lab & Allied’s Paracetamol Syrup, instead of higher-priced imported products. Economic constraints bear a strong influence on purchasing decisions, with parents opting for more cost-effective alternatives like Calpol for children’s fever and pain relief, rather than premium brands like Panadol Baby &

Demand for paediatric consumer health in South Africa continues to grow in 2024, driven by the highest value categories of cough, cold and allergy remedies, vitamins and dietary supplements, and digestive remedies. Despite ongoing inflationary pressures in the country, which continue to push up unit prices, and where many local consumers remain under significant financial strain, thereby forcing them to prioritise their spending, they continue to focus on the wellbeing of their children.

Paediatric consumer health is set to see current value growth in 2024. In line with the general consumer desire to adopt a healthier lifestyle, parents are becoming particularly interested in finding the best paediatric vitamins for their children. This desire has contributed to retail value growth during 2024. Detailed articles about what are the best vitamin products for children often appear in the local press, resonating with parental concern about children’s health. Moreover, parents have a

In Latvia, paediatric consumer health has seen a strong recovery in demand after the COVID-19 pandemic. As kids returned to schools and daycare settings, there was a noticeable uptick in consumer interest for children’s vitamins, cough syrups, and other OTC remedies. Brands like Brontex and Linex Kids are gaining popularity as parents look to protect their kids from the common bugs that are shared in school-time. This demonstrates that families are getting back to normal routines and are more fo